4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS

PROBLEM TO BE SOLVED: To provide compounds useful for the treatment of Brutons Tyrosine Kinase (Btk) mediated disorders.SOLUTION: The present invention relates to 6-5 membered fused pyridine ring compounds represented by the following formula.SELECTED DRAWING: None 【課題】ブルトン型チロシンキナーゼ（Ｂｔｋ）媒介障害の処置に有効な化...

Full description

Saved in:
Bibliographic Details
Main Authors JOHANNES BERNARDUS MARIA REWINKEL, DE ADRIANUS PETRUS ANTONIUS MAN, HANS C A RAAIJMAKERS, CHRISTIAAN GERARDUS JOHANNES MARIA JANS, JACOBUS C H M WIJKMANS, TJEERD A BARF, JAN-GERARD STERRENBURG, ARTHUR A OUBRIE
Format Patent
LanguageEnglish
Japanese
Published 08.03.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide compounds useful for the treatment of Brutons Tyrosine Kinase (Btk) mediated disorders.SOLUTION: The present invention relates to 6-5 membered fused pyridine ring compounds represented by the following formula.SELECTED DRAWING: None 【課題】ブルトン型チロシンキナーゼ（Ｂｔｋ）媒介障害の処置に有効な化合物の提供。【解決手段】下記式を代表例とする６〜５員縮合ピリジン環化合物。【選択図】なし
Bibliography:Application Number: JP20170198591